- Home
- STRM vs UBX Comparison
STRM vs UBX Comparison
Compare STRM & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- UBX
- Stock Information
- Founded
- STRM 1989
- UBX 2009
- Country
- STRM United States
- UBX United States
- Employees
- STRM N/A
- UBX N/A
- Industry
- STRM EDP Services
- UBX Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- UBX Health Care
- Exchange
- STRM Nasdaq
- UBX Nasdaq
- Market Cap
- STRM 15.4M
- UBX 12.7M
- IPO Year
- STRM 1996
- UBX 2018
- Fundamental
- Price
- STRM $5.18
- UBX $0.72
- Analyst Decision
- STRM
- UBX Strong Buy
- Analyst Count
- STRM 0
- UBX 3
- Target Price
- STRM N/A
- UBX $4.67
- AVG Volume (30 Days)
- STRM 180.1K
- UBX 195.7K
- Earning Date
- STRM 06-10-2025
- UBX 04-22-2025
- Dividend Yield
- STRM N/A
- UBX N/A
- EPS Growth
- STRM N/A
- UBX N/A
- EPS
- STRM N/A
- UBX N/A
- Revenue
- STRM $17,901,000.00
- UBX N/A
- Revenue This Year
- STRM $18.64
- UBX N/A
- Revenue Next Year
- STRM N/A
- UBX N/A
- P/E Ratio
- STRM N/A
- UBX N/A
- Revenue Growth
- STRM N/A
- UBX N/A
- 52 Week Low
- STRM $1.82
- UBX $0.66
- 52 Week High
- STRM $9.75
- UBX $3.10
- Technical
- Relative Strength Index (RSI)
- STRM 84.54
- UBX 35.48
- Support Level
- STRM $2.07
- UBX $0.66
- Resistance Level
- STRM $5.20
- UBX $0.81
- Average True Range (ATR)
- STRM 0.14
- UBX 0.08
- MACD
- STRM 0.34
- UBX 0.00
- Stochastic Oscillator
- STRM 99.21
- UBX 21.49
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.